1S5B image
Deposition Date 2004-01-20
Release Date 2004-04-06
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1S5B
Title:
Cholera holotoxin with an A-subunit Y30S mutation Form 3
Biological Source:
Source Organism:
Vibrio cholerae (Taxon ID: 666)
Method Details:
Experimental Method:
Resolution:
2.13 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cholera enterotoxin, A chain precursor
Gene (Uniprot):ctxA
Mutations:Y30S
Chain IDs:A
Chain Length:240
Number of Molecules:1
Biological Source:Vibrio cholerae
Polymer Type:polypeptide(L)
Molecule:cholera toxin B protein (CTB)
Gene (Uniprot):ctxB
Chain IDs:B (auth: D), C (auth: E), D (auth: F), E (auth: G), F (auth: H)
Chain Length:103
Number of Molecules:5
Biological Source:Vibrio cholerae
Ligand Molecules
Primary Citation
Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism
Biochemistry 43 3772 3782 (2004)
PMID: 15049684 DOI: 10.1021/bi0360152

Abstact

Cholera toxin (CT) is a heterohexameric bacterial protein toxin belonging to a larger family of A/B ADP-ribosylating toxins. Each of these toxins undergoes limited proteolysis and/or disulfide bond reduction to form the enzymatically active toxic fragment. Nicking and reduction render both CT and the closely related heat-labile enterotoxin from Escherichia coli (LT) unstable in solution, thus far preventing a full structural understanding of the conformational changes resulting from toxin activation. We present the first structural glimpse of an active CT in structures from three crystal forms of a single-site A-subunit CT variant, Y30S, which requires no activational modifications for full activity. We also redetermined the structure of the wild-type, proenzyme CT from two crystal forms, both of which exhibit (i) better geometry and (ii) a different A2 "tail" conformation than the previously determined structure [Zhang et al. (1995) J. Mol. Biol. 251, 563-573]. Differences between wild-type CT and active CTY30S are observed in A-subunit loop regions that had been previously implicated in activation by analysis of the structure of an LT A-subunit R7K variant [van den Akker et al. (1995) Biochemistry 34, 10996-11004]. The 25-36 activation loop is disordered in CTY30S, while the 47-56 active site loop displays varying degrees of order in the three CTY30S structures, suggesting that disorder in the activation loop predisposes the active site loop to a greater degree of flexibility than that found in unactivated wild-type CT. On the basis of these six new views of the CT holotoxin, we propose a model for how the activational modifications experienced by wild-type CT are communicated to the active site.

Legend

Protein

Chemical

Disease

Primary Citation of related structures